Found: 14
Select item for more details and to access through your institution.
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 9, p. 1, doi. 10.1093/ofid/ofae453
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 12, p. 1528, doi. 10.1002/jcph.773
- By:
- Publication type:
- Article
Multiple-Dose Administration of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Does Not Alter the Single-Dose Pharmacokinetics of Rosiglitazone in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2007, v. 47, n. 2, p. 159, doi. 10.1177/0091270006297007
- By:
- Publication type:
- Article
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00885-1
- By:
- Publication type:
- Article
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 71, doi. 10.1093/infdis/jiac407
- By:
- Publication type:
- Article
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad417
- By:
- Publication type:
- Article
2775. Safety and Immunogenicity of a Seasonal Influenza Vaccine and Ad26.RSV.preF Vaccine With and Without Co-Administration: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study in Adults Aged ≥ 60 Years.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S979, doi. 10.1093/ofid/ofz360.2452
- By:
- Publication type:
- Article
2712. Safety and Immunogenicity of two Doses of ExPEC4V Vaccine Against Extraintestinal Pathogenic Escherichia coli Disease in Healthy Adult Participants.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S954, doi. 10.1093/ofid/ofz360.2389
- By:
- Publication type:
- Article
902. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of a Single Immunization of Ad26.RSV.preF against RSV Infection in a Viral Challenge Model in Healthy Adults.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S27, doi. 10.1093/ofid/ofz359.061
- By:
- Publication type:
- Article
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 8, p. 1815, doi. 10.1111/bcp.13269
- By:
- Publication type:
- Article
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A human anti-D monoclonal antibody selected for enhanced FcγRIII engagement clears RhD<sup>+</sup> autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 1, p. 109, doi. 10.1111/j.1365-2141.2008.06985.x
- By:
- Publication type:
- Article